SCHEMBL30849833

SCHEMBL30849833

Cc1cccc(B2OCC(C)(C)O2)c1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28546786 0.83 TSHR (0.31)
SCHEMBL29592082 0.79 ALDH1A1 (0.30)
SCHEMBL13601620 0.78 LPL (0.41)
SCHEMBL24422669 0.75 CYP3A4 (0.39)
SCHEMBL28589703 0.75 JAK2 (0.38)
SCHEMBL28499705 0.73 ALDH1A1 (0.37)
SCHEMBL28622364 0.73
SCHEMBL29592069 0.72 TAAR1 (0.33)
SCHEMBL2658980 0.70 GABRA1 (0.32)
SCHEMBL28516479 0.69 LPL (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117800975-A Compounds with anti-KRAS mutant tumor activity 泰励生物科技(上海)有限公司 2024-04-02 CN disclosed